发明名称 USE OF INTERLEUKIN-1 CONJUGATES IN THE TREATMENT OF DIABETES
摘要 The invention provides compositions, pharmaceutical compositions and vaccines for the treatment, amelioration and / or prophylaxis of diabetes, preferably of type II diabetes. The compositions, pharmaceutical compositions and vaccines of the invention comprise a core particle and an antigen, wherein said antigen comprises an interleukin-1 (IL-I) molecule. When administered to an animal, preferably to a human, said compositions, pharmaceutical compositions, and vaccines induce efficient immune responses, in particular antibody responses, wherein typically and preferably said antibody responses are directed against IL-I. Thus, the invention provides methods of treating, ameliorating or preventing diabetes, preferably type II diabetes, by way of active immunization against IL-I.
申请公布号 WO2009109643(A2) 申请公布日期 2009.09.11
申请号 WO2009EP52639 申请日期 2009.03.05
申请人 CYTOS BIOTECHNOLOGY AG;BACHMANN, MARTIN;SPOHN, GUNTHER 发明人 BACHMANN, MARTIN;SPOHN, GUNTHER
分类号 A61K38/20;A61K39/12;A61P3/10;C07K14/545 主分类号 A61K38/20
代理机构 代理人
主权项
地址